Cressey, T. R., Avihingsanon, A., Halue, G., Leenasirimakul, P., Sukrakanchana, P. O., Tawon, Y., . . . Bowonwatanuwong, C. (2018). Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment.
Chicago Style CitationCressey, Tim R., et al. Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 Mg Every 48 Hours Vs 150 Mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment. 2018.
MLA引文Cressey, Tim R., et al. Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 Mg Every 48 Hours Vs 150 Mg Once Daily in HIV-Infected Adults With Moderate Renal Function Impairment. 2018.